Cite
HARVARD Citation
Ziegler, D. et al. (n.d.). 366PActivity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ziegler, D. et al. (n.d.). 366PActivity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours. Annals of oncology. p. . [Online].